One in three women struggles with a pelvic floor disorder, but many do not seek treatment. Learn more about these disorders.
Quality, Equity & Safety
The Department of Obstetrics and Gynecology at Massachusetts General Hospital is committed to providing the highest quality patient care and safety.
Rachel M. Sisodia, MD, a gynecologic oncologist with the Massachusetts General Hospital Department of Obstetrics & Gynecology and the Mass General Cancer Center, discusses a Mass General study investigating how to reduce readmissions in patients undergoing treatment for ovarian cancer.
In 2009, the federal government calculated that the United States spends more than $2.2 trillion each year on health care, which is 16% of our national budget. That same year, a sentinel study was published in the New England Journal of Medicine showing that approximately one in five Medicare patients will have an unplanned readmission to the hospital within 30 days of their discharge to home. The combined cost of these readmissions was more than $17 billion.
Readmissions may be expensive, but they are also costly in other regards. For oncology patients in particular, readmission can delay chemotherapy or radiation treatments, create exposure to hospital acquired infections, increase stress on a patient and their caregivers, and reduce the patient’s ability to spend time with family and friends. Most of the data surrounding readmissions are complex, making readmissions difficult to predict and often unpreventable.
In 2013, the Division of Gynecologic Oncology at Mass General investigated our own readmission rates. The primary goal of the study was to identify patterns which predict the patients that will be readmitted; the ultimate goal was to figure out a way to prevent these readmissions from happening. In order to do this, we looked first at our highest-risk patients: women undergoing debulking surgery for ovarian cancer. These are extensive surgeries, often requiring the removal of multiple organs.
In our study, we reviewed all patients undergoing surgery for advanced ovarian cancer at Mass General for the past 11 years; the study included almost 500 women. We found that overall, these patients have a one in ten chance of being readmitted within 30 days after surgery. Most commonly this was due to a wound infection, but there were a variety of other reasons. Surprisingly, elderly and sick patients were no more likely to be readmitted than younger, healthier women. In fact, the only predictor for readmission was having a complication with the initial surgery. For example, if a patient had a blood clot that travelled to their lungs in the initial postoperative period, their risk of readmission was three times higher than those that did not. Infections, re-operation, high blood loss and unplanned admission to the intensive care unit also predicted for readmission. In summary, for patients without complications the risk of readmission was 1 in 25. However, once a patient had two complications their risk of readmission rose to 1 in 3.
We are using the results of this study to create a "high risk" postoperative care bundle for our gynecologic-oncology patients to help reduce readmissions. This may occur in the form of nursing phone calls, extra resources for home, and earlier and more frequent doctor’s appointments. Our hope is that by looking back at previous cases, we will identify ways to reduce all preventable readmissions, helping our patients heal faster in the comfort of their home.
The study was published in the journal Gynecologic Oncology.
- Nov | 13 | 2019
Episode #31 of the Charged podcast
- Nov | 12 | 2019
About half of women who have been through menopause suffer from vaginal dryness or discomfort, which can interfere with their ability to enjoy sex. The women's health experts at Massachusetts General Hospital have published research showing that safe, effective treatments can make a big difference.
- Staff Story
- Oct | 23 | 2019
New Doctor Q&A: Shruthi Mahalingaiah, MD
- Staff Story
- Oct | 23 | 2019
New Doctor Q&A: Irene Dimitriadis, MD
- Press Release
- Jun | 13 | 2019
A study based at the Ragon Institute of MGH, MIT and Harvard has determined how a pregnant woman’s vaccine-induced immunity is transferred to her child, which has implications for the development of more effective maternal vaccines.
OB/GYN at Mass General
The Department of Obstetrics & Gynecology at Mass General consistently ranks among the best women's health care providers in the country, offering innovative treatments from leading experts in obstetrics, gynecology, infertility, cancer, and urogynecology. Learn more about our department.